Relationship Between Simulated Gadolinium-Based Contrast Agent Injection Profile and Achievable Resolution Metrics in Contrast-Enhanced Magnetic Resonance Angiography

被引:2
|
作者
Clark, Toshimasa J. [1 ]
Wilson, Gregory J. [2 ]
Maki, Jeffrey H. [1 ]
机构
[1] Univ Colorado, Dept Radiol, Abdominal Imaging Sect, Aurora, CO USA
[2] Bayer Healthcare, Bayer Radiol, Whippany, NJ USA
关键词
magnetic resonance angiography; contrast-enhanced magnetic resonance angiography; simulation; GADOBENATE DIMEGLUMINE; LIMITS;
D O I
10.1002/jmri.27966
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Contrast bolus variation during contrast-enhanced magnetic resonance angiography (CE-MRA) acquisition may lead to vessel blurring. Purpose To combine knowledge of how contrast signal intensity (SI) evolves for different injection strategies with anatomically familiar parametric computer models to measure and visually assess the effects of a wide range of variables on modeled CE-MRA, and in doing so develop contrast rate injection guidelines. Study Type Computer modeling. Phantom Digital three-dimensional phantom consisting of orthogonal "aorta," 7 mm diameter "renal arteries" (with 57% and 86% diameter stenoses), and 7 mm diameter "superior mesenteric artery" (with 57% diameter stenosis). Field Strength/Sequence One millimeter in-plane resolution arterial CE-MRA imaging at 3 T. Assessment "Background" (time invariant) and "vascular" (time varying) components of the phantom were each Fourier transformed into the spatial frequency domain, the latter modulated by the SI evolution of a contrast bolus of varying "plateau" lengths and "tail" heights. Data are presented as surface plots of stenosis measurement error and blurring vs. a reference-standard injection. Statistical Tests Descriptive. Results Shorter plateau lengths and lower tail heights resulted in increased measured stenosis error and blurring vs. the reference standard. Under a 44-second acquisition, full width half maximum stenosis error of the 86% stenosis with 25% plateau length and 25% tail height is 24% as compared to that from the reference standard. As plateau length and tail height approach 100%, stenosis error and blurring approach a floor defined by the MR acquisition's limitations. Data Conclusion We propose that to achieve minimal degradation with CE-MRA, one can create a contrast bolus with either 60% plateau and 50% tail height or 80% plateau with any tail. These considerations may well prove to be of practical importance, possibly via manipulating the tail by means of multiphasic contrast injections. Level of Evidence 3 Technical Efficacy Stage 1
引用
收藏
页码:1797 / 1807
页数:11
相关论文
共 50 条
  • [21] Gadolinium-based contrast agents in pediatric magnetic resonance imaging
    Eric M. Gale
    Peter Caravan
    Anil G. Rao
    Robert J. McDonald
    Matthew Winfeld
    Robert J. Fleck
    Michael S. Gee
    Pediatric Radiology, 2017, 47 : 507 - 521
  • [22] Gadolinium-based contrast agents in pediatric magnetic resonance imaging
    Gale, Eric M.
    Caravan, Peter
    Rao, Anil G.
    McDonald, Robert J.
    Winfeld, Matthew
    Fleck, Robert J.
    Gee, Michael S.
    PEDIATRIC RADIOLOGY, 2017, 47 (05) : 507 - 521
  • [23] Gadolinium-based contrast agents for magnetic resonance cancer imaging
    Zhou, Zhuxian
    Lu, Zheng-Rong
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2013, 5 (01) : 1 - 18
  • [24] Pharmacokinetics of gadoversetamide injection, a gadolinium-based contrast agent, in pediatric patients
    Wible, James H.
    Tata, Prasad N. V.
    Napoli, Alicia M.
    Lowe, Lisa H.
    Kearns, Gregory L.
    MAGNETIC RESONANCE IMAGING, 2009, 27 (04) : 512 - 518
  • [25] Optimization of the Contrast Agent Injection Protocol for Carotid Artery Dynamic Contrast-Enhanced Magnetic Resonance Imaging
    Wang, Yajie
    Liu, Xiaoming
    Wang, Yishi
    Qi, Haikun
    Liu, Xian
    Kong, Xiangchuang
    Zhang, Qiang
    Dou, Jiaqi
    Wang, Jing
    Chen, Huijun
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 56 (05) : 1372 - 1381
  • [26] Uptake of Gadolinium-Based Contrast Agents by Blood Cells During Contrast-Enhanced MRI Examination
    Ruprecht, Nico
    Parakkattel, Dixy
    Hofmann, Lukas
    Broekmann, Peter
    Ludi, Nicola
    Kempf, Christoph
    Heverhagen, Johannes Thomas
    von Tengg-Kobligk, Hendrik
    INVESTIGATIVE RADIOLOGY, 2024, 59 (05) : 372 - 378
  • [27] Contrast-Enhanced Magnetic Resonance Angiography in Rabbits Evaluation of the Gadolinium-Based Agent P846 and the Iron-Based Blood Pool Agent P904 in Comparison With Gadoterate Meglumine
    Kinner, Sonja
    Maderwald, Stefan
    Parohl, Nina
    Albert, Juliane
    Corot, Claire
    Robert, Philippe
    Barkhausen, Joerg
    Vogt, Florian M.
    INVESTIGATIVE RADIOLOGY, 2011, 46 (08) : 524 - 529
  • [28] Impact of Gadolinium-Based Contrast Agent in the Assessment of Crohn's Disease Activity: Is Contrast Agent Injection Necessary?
    Quaia, Emilio
    Sozzi, Michele
    Gennari, Antonio Giulio
    Pontello, Michele
    Angileri, Roberta
    Cova, Maria Assunta
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2016, 43 (03) : 688 - 697
  • [29] Contrast-enhanced magnetic resonance angiography of peripheral vessels - Different contrast agent applications and sequence strategies: A review
    Boos, M
    Lentschig, M
    Scheffler, K
    Bongartz, GM
    Steinbrich, W
    INVESTIGATIVE RADIOLOGY, 1998, 33 (09) : 538 - 546
  • [30] Contrast-enhanced magnetic resonance coronary angiography: first experience using an albumin bound contrast agent in humans
    Regenfus, M
    Ropers, D
    Achenbach, S
    Daniel, WG
    Laub, G
    Moshage, W
    EUROPEAN HEART JOURNAL, 2000, 21 : 565 - 565